References
- TreedeRDJensenTSCampbellJNNeuropathic pain: Redefinition and a grading system for clinical and research purposesNeurology200870181630163518003941
- HernándezJNHernándezJMorenoCUse of lidocaine patches in the relief of localised neuropathic painRev Iberoamericana del Dolor2009141328
- de Leon-CasasolaOAMultimodal approaches to the management of neuropathic pain: The role of topical analgesiaJ Pain Symptom Manag2007333356364
- WasnerGKleinertABinderASchattschneiderJBaronRPostherpetic neuralgia: Topical lidocaine is effective in nociceptor-deprived skinJ Neurol2005252667768615778907
- RowbothamMCDaviesPSVerkempinckCGalerBSLidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgiaPain199665139448826488
- GalerBSRowbothamMCPeranderJFriedmanETopical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: Results of an enriched enrolment studyPain19998053353810342414
- BinderABruxelleJRogersPHansGBöslIBaronRTopical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: Results of a double-blind, placebo-controlled, multinational efficacy and safety trialClin Drug Investig2009296393408
- HansGSabatowskiRBinderABoeslIRogersPBaronREfficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: Results of a long-term studyCurr Med Res Opin20092551295130519366301
- DworkinRHBackonjaMRowbothamMCAdvances in neuropathic painArch Neurol200360111524153414623723
- FinnerupNBOttoMMcQuayHJJensenTSSindrupSHAlgorithm for neuropathic pain treatment: An evidence based proposalPain2005118328930516213659
- AcevedoJCAmayaAde León CasasolaO[Guidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American experts]Rev Iberoamericana del Dolor200821546
- HaanpääMMechanism-based treatment of herpes zoster and postherpetic neuralgiaEur J Pain200711138
- RehmSBinderABaronRPost-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness studyCurr Med Res Opin20102671607161920429825
- BouhassiraDAttalNAlchaarHComparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagn ostic questionnaire (DN4)Pain20051141–2293615733628
- PerezCGalvezRHuelbesSValidity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic componentHealth Qual Life Outcomes200756618053212
- BenowitzNLMeisterWClinical pharmacokinetics of lignocaineClin Pharmacokinet197833177201350470
- EstesNAManolisASGreenblattDJGaranHRuskinJNTherapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusionAm Heart J19891175106010642711965
- JürgensGGraudalNAKampmannJPTherapeutic drug monitoring of antiarrhythmic drugsClin Pharmacokinet20034264766312844326
- GianellyRvon der GroebenJOSpivackAPHarrisonDCEffect of lidocaine on ventricular arrhythmias in patients with coronary heart diseaseN Engl J Med196727723121512194862377
- LieKIWellensHJJvan CapelleFJDurrerDLidocaine in the prevention of primary ventricular fibrillation: A double-blind, randomized study of 212 consecutive patientsN Engl J Med197429125132413264610392
- HansGJoukesEVerhulstJVercauterenMManagement of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: Study of 40 consecutive casesCurr Med Res Opin200925112737274319788351
- DaviesPSGalerBSReview of 5% lidocaine medicated plaster studies in the treatment of postherpetic neuralgiaDrugs200464993794715101784
- BarbanoRLHermannDNHart-GouleauSPennella-VaughanJLodewickPADworkinRHEffectiveness, tolerability and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathyArch Neurol200461691491815210530
- NayakSCunliffeMCase report: Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: Report of five casesPediatric Anesthesia200818655455818363625
- LiedgensHHertelNGabrielACost-effectiveness analysis of a 5% lidocaine medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: A German perspectiveClin Drug Investig2008289583601
- RitchieMLiedgensHNuijtenMCost effectiveness of a 5% lidocaine medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: A Markov model analysisClin Drug Investig20103027187
- GustorffBTopical lidocaine – experimental models of neuropathic pain and implications for symptomatic treatmentEur J Pain200711S1S55
- SjölundKFSegerdahlMSolleviAAdenosine reduces secondary hyperalgesia in two human models of cutaneous inflammatory painAnesth Analg199988360561010072015
- AndoKWallaceMSBraunJSchulteisGEffect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: A double-blind, placebo-controlled, crossover studyReg Anesth Pain Med200025546847411009231
- SychaTAnzenhoferSLehrSRofecoxib attenuates both primary and secondary inflammatory hyperalgesia: A randomized, double blinded, placebo controlled crossover trial in the UV-B pain modelPain2005113331632215661439